Mohamed R. Elnagar

577 total citations
29 papers, 458 citations indexed

About

Mohamed R. Elnagar is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mohamed R. Elnagar has authored 29 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Mohamed R. Elnagar's work include Enzyme function and inhibition (5 papers), Quinazolinone synthesis and applications (5 papers) and Synthesis and biological activity (3 papers). Mohamed R. Elnagar is often cited by papers focused on Enzyme function and inhibition (5 papers), Quinazolinone synthesis and applications (5 papers) and Synthesis and biological activity (3 papers). Mohamed R. Elnagar collaborates with scholars based in Egypt, Saudi Arabia and Iraq. Mohamed R. Elnagar's co-authors include Nora M. Aborehab, Gouda K. Helal, Alaadin E. El-Haddad, Farid M.A. Hamada, Morten S. Thomsen, Anne B. Walls, Anders A. Jensen, Sameh H. Soror, Ayman A. Soubh and Hamdoon A. Mohammed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mohamed R. Elnagar

24 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohamed R. Elnagar Egypt	12	207	150	62	45	45	29	458
Jae‐Hwan Kwak South Korea	18	262 1.3×	301 2.0×	81 1.3×	68 1.5×	52 1.2×	63	783
Md Quamrul Hassan India	13	163 0.8×	153 1.0×	34 0.5×	40 0.9×	48 1.1×	21	516
Alfons Nonell‐Canals Spain	14	258 1.2×	165 1.1×	57 0.9×	64 1.4×	26 0.6×	20	599
Li‐Jiau Huang Taiwan	12	202 1.0×	115 0.8×	32 0.5×	45 1.0×	40 0.9×	16	436
Mohammad M. Abd‐Alhaseeb Egypt	14	188 0.9×	84 0.6×	45 0.7×	87 1.9×	31 0.7×	26	468
Richard Moon Switzerland	7	177 0.9×	78 0.5×	45 0.7×	35 0.8×	61 1.4×	11	422
Wei Ney Yap Singapore	13	342 1.7×	112 0.7×	74 1.2×	31 0.7×	28 0.6×	22	762
Najla O. Zarmouh United States	12	166 0.8×	51 0.3×	51 0.8×	66 1.5×	31 0.7×	20	372
Elbert L. Myles United States	10	150 0.7×	70 0.5×	42 0.7×	47 1.0×	22 0.5×	19	441
Wafaa S. Ramadan United Arab Emirates	14	346 1.7×	70 0.5×	103 1.7×	60 1.3×	53 1.2×	39	627

Countries citing papers authored by Mohamed R. Elnagar

Since Specialization

Citations

This map shows the geographic impact of Mohamed R. Elnagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed R. Elnagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed R. Elnagar more than expected).

Fields of papers citing papers by Mohamed R. Elnagar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed R. Elnagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed R. Elnagar. The network helps show where Mohamed R. Elnagar may publish in the future.

Co-authorship network of co-authors of Mohamed R. Elnagar

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed R. Elnagar. A scholar is included among the top collaborators of Mohamed R. Elnagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed R. Elnagar. Mohamed R. Elnagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ismail, Magda M. F., et al.. (2025). New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers. Bioorganic Chemistry. 156. 108182–108182. 3 indexed citations

Eldehna, Wagdy M., Zainab M. Elsayed, Mohamed R. Elnagar, et al.. (2025). Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitization. RSC Medicinal Chemistry. 17(2). 965–986.

Salem, Mohamed S. H., et al.. (2025). Dialkyloxyphenyl hybrids as PDE4B inhibitors: Design, synthesis, in vitro/in vivo anti-inflammatory activity and in silico insights. Bioorganic Chemistry. 161. 108511–108511. 1 indexed citations

Hassan, Rasha A., Zeinab Mahmoud, Ayman Abo Elmaaty, et al.. (2025). Design, synthesis, and anticancer evaluation of new Quinazoline hybrids: DNA intercalation, topoisomerase IIα inhibition, and in silico studies. Bioorganic Chemistry. 164. 108921–108921.

Eldehna, Wagdy M., Mohamed R. Elnagar, Simone Giovannuzzi, et al.. (2025). Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activity. Bioorganic Chemistry. 166. 109071–109071. 2 indexed citations

Al‐Sanea, Mohammad M., Mohamed R. Elnagar, Maha‐Hamadien Abdulla, et al.. (2025). Design and synthesis of novel 2-S-alkylated Quinazolinones as dual BRAFV600E and EGFR inhibitors in melanoma: Mechanistic insights from apoptosis and cell cycle modulation. Bioorganic Chemistry. 161. 108526–108526.

Hamdi, Abdelrahman, Mohamed R. Elnagar, Adel S. El‐Azab, et al.. (2025). Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition. Bioorganic Chemistry. 166. 109162–109162.

Abdel‐Latif, Ehab, et al.. (2024). Development of non-acidic 4-methylbenzenesulfonate-based aldose reductase inhibitors; Design, Synthesis, Biological evaluation and in-silicostudies. Bioorganic Chemistry. 151. 107666–107666. 5 indexed citations

Elnagar, Mohamed R., et al.. (2024). Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53–SIRT1 dependent pathway. Heliyon. 10(19). e38081–e38081. 5 indexed citations

10.

Hamdi, Abdelrahman, M. A. Bhat, Noha I. Ziedan, et al.. (2023). Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2231170–2231170. 20 indexed citations

11.

Elnagar, Mohamed R., et al.. (2023). ASSESSMENT OF THREE HEAT TREATED SINGLE FILE SYSTEMS IN GUTTA-PERCHA REMOVAL USING CONE BEAM COMPUTED TOMOGRAPHY (AN IN VITRO STUDY). Alexandria Dental Journal. 48(3). 124–131.

12.

Abdallah, Abdallah E., Mohamed R. Elnagar, Amel M. Farrag, et al.. (2022). New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation. SHILAP Revista de lepidopterología. 41 indexed citations

13.

Elnagar, Mohamed R., Eman Hamza, Eman Mohamad El Nashar, et al.. (2022). Neuroprotective effect of naringin against cerebellar changes in Alzheimer’s disease through modulation of autophagy, oxidative stress and tau expression: An experimental study. Frontiers in Neuroanatomy. 16. 1012422–1012422. 43 indexed citations

14.

Soror, Sameh H., et al.. (2021). Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy. Molecules. 26(2). 506–506. 15 indexed citations

15.

Elnagar, Mohamed R., et al.. (2021). Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy. Biomedicine & Pharmacotherapy. 145. 112122–112122. 31 indexed citations

16.

Elnagar, Mohamed R., et al.. (2021). Morin alleviates hepatic ischemia/reperfusion-induced mischief: In vivo and in silico contribution of Nrf2, TLR4, and NLRP3. Biomedicine & Pharmacotherapy. 138. 111539–111539. 23 indexed citations

17.

Abd‐Allah, Adel R. A., et al.. (2020). PEG-SOD attenuates the mitogenic ERK1/2 signaling cascade induced by cyclosporin A in the liver and kidney of albino mice. Chemico-Biological Interactions. 330. 109245–109245. 5 indexed citations

18.

Elnagar, Mohamed R., et al.. (2019). Increasing cellular lifespan with a flow system in organotypic culture of the Laterodorsal Tegmentum (LDT). Scientific Reports. 9(1). 1486–1486. 9 indexed citations

19.

Elnagar, Mohamed R., Anne B. Walls, Gouda K. Helal, et al.. (2018). Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay. European Journal of Pharmacology. 826. 106–113. 48 indexed citations

20.

Elnagar, Mohamed R., Anne B. Walls, Gouda K. Helal, et al.. (2017). Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue. PLoS ONE. 12(12). e0189513–e0189513. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact